Prevalence of occult Hepatitis B in patients infected with the hepatitis C will be treated with oral direct acting antivirals

dc.creatorAlmeida, Nathália Alves Araujo de
dc.creatorBarros, José Junior França de
dc.creatorCampos, Letícia Bomfim
dc.creatorSpitz, Natália
dc.creatorBrandão, Carlos Eduardo
dc.creatorSantana, Catarina Góis de
dc.creatorPaula, Vanessa Salete de
dc.date.accessioned2019-04-29T13:00:41Z
dc.date.accessioned2023-09-05T11:40:54Z
dc.date.available2019-04-29T13:00:41Z
dc.date.available2023-09-05T11:40:54Z
dc.date.created2019-04-29T13:00:41Z
dc.date.issued2019
dc.identifierALMEIDA, N. A. A. et al. Prevalence of occult Hepatitis B in patients infected with the hepatitis C will be treated with oral direct acting antivirals. In: INTERNATIONAL SYMPOSIUM ON IMMUNOBIOLOGICAL, 4., 2019; SEMINÁRIO ANUAL CIENTÍFICO E TECNOLÓGICO DE BIO-MANGUINHOS, 7., 2019, Rio de Janeiro. Anais... Rio de Janeiro: Bio-Manguinhos, 2019. p. 167.
dc.identifierhttps://www.arca.fiocruz.br/handle/icict/32819
dc.identifier10.35259/isi.sact.2019_32819
dc.identifier.urihttps://repositorioslatinoamericanos.uchile.cl/handle/2250/8638849
dc.languageeng
dc.publisherFiocruz/Instituto de Tecnologia em Imunobiológicos
dc.rightsopen access
dc.titlePrevalence of occult Hepatitis B in patients infected with the hepatitis C will be treated with oral direct acting antivirals
dc.typePapers presented at events


Este ítem pertenece a la siguiente institución